Serum-Free Adipocyte Differentiation Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current serum-based media for differentiating adipogenic progenitor cells into adipocytes pose health risks due to potential bacterial, viral, and prionic contaminants, ethical concerns regarding animal welfare, and high costs, while serum-free alternatives struggle to match differentiation efficiency and safety standards for human consumption.
Innovation Solution
A serum-free, chemically defined medium comprising PPARγ agonists, hormones like insulin and hydrocortisone, cytokines such as BMP4 and EGF, and ascorbic acid, which effectively differentiates mammalian adipogenic progenitor cells into adipocytes without using hazardous inducers like IBMX, dexamethasone, and rosiglitazone, ensuring food compatibility and safety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If serum-based media is used for adipogenic differentiation, then differentiation efficiency is improved, but health safety and animal welfare deteriorate due to contaminants and ethical concerns
Solution Approach 1:
The invention extracts and eliminates serum from the culture medium while retaining the essential adipogenic differentiation function through a chemically defined formulation containing specific growth factors, hormones, and nutrients. This removes the harmful contaminants (bacteria, viruses, prions) and ethical concerns associated with serum while maintaining differentiation efficiency.
Solution Approach 2:
The invention changes the chemical composition parameters of the culture medium by replacing serum with a precisely defined mixture of components including PPARγ agonists, insulin, hydrocortisone, BMP4, EGF, and ascorbic acid. This parameter change achieves both safety (no contaminants) and functionality (effective differentiation).
2Object-affected harmful factors
If conventional serum-free media is used, then health safety is improved, but differentiation efficiency deteriorates compared to serum-based media
Solution Approach 1:
The invention optimizes the concentration and combination of chemically defined components to achieve superior differentiation efficiency. The specific formulation including PPARγ agonists (1-100 nM), insulin (1-10 μg/mL), hydrocortisone (10-100 nM), BMP4 (1-100 ng/mL), EGF (1-10 μg/mL), and ascorbic acid (10-100 μM) creates optimal conditions for adipogenic differentiation while maintaining serum-free safety.
Solution Approach 2:
The invention uses a composite formulation combining multiple bioactive components that work synergistically to achieve effective adipogenic differentiation. The combination of PPARγ agonists, hormones (insulin, hydrocortisone), growth factors (BMP4, EGF), and nutrients (ascorbic acid, amino acids, vitamins) creates a composite medium that outperforms conventional serum-free media.
3Reliability
If conventional differentiation inducers (IBMX, dexamethasone, rosiglitazone) are used, then adipogenic differentiation is achieved, but food compatibility deteriorates due to hazardous compounds
Solution Approach 1:
The invention extracts and removes hazardous differentiation inducers (IBMX, dexamethasone, rosiglitazone) from the culture medium while maintaining adipogenic differentiation capability through alternative safe components. This eliminates food safety concerns while achieving the same biological effect.
Solution Approach 2:
The invention uses food-compatible, biodegradable components that can be completely removed or degraded before product consumption. The chemically defined medium uses substances that are either naturally present in food or can be easily eliminated, replacing persistent hazardous compounds with transient safe alternatives.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The serum-free medium outperforms traditional media in adipogenic differentiation potential, allowing for safe and efficient production of cultured fat and meat products for human consumption, reducing waste and microbial contamination, and eliminating the need for animal-derived components.
Implementation Method 1
the serum-free medium comprises: at least one peroxisome proliferator-activated receptor gamma (PPARγ) agonist
Implementation Method 2
at least one hormone selected from the group consisting of insulin and hydrocortisone
Implementation Method 3
at least one cytokine and/or growth factor selected from the group consisting of bone morphogenetic protein 4 (BMP4) and epidermal growth factor (EGF)
Implementation Method 4
ascorbic acid or a derivative thereof
Data Source
AI summary
The invention provides inter alia a method for differentiating an adipogenic progenitor cell. comprising the step of:—culturing an adipogenic progenitor cell in a serum-free medium for differentiating an adipogenic progenitor cell. wherein the serum-free medium comprises:—at least one peroxisome proliferator-activated receptor gamma (PPARy) agonist:—at least one hormone selected from the group consisting of insulin and hydrocortisone:—at least one cytokine and/or growth factor selected from the group consisting of bone morphogenetic protein 4 (BMP4) and epidermal growth factor (EGF); and-ascorbic acid or a derivative thereof.